Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nick, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Krueger, Karl, Ph.D. [V]
karl.krueger@nih.gov
Volunteer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Program Officer | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Villanueva, Juan Miguel
juan.villanueva@nih.gov
5E630 Program Analyst | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-03 Matthew Young, Ph.D.
Huang, Yijian

Emory University
United States

Analytic diagnosis methods for disease ruling 5R01CA283687-02 Guillermo Marquez, Ph.D.
Hur, Chin

Columbia University Health Sciences
United States

Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 5R01CA257333-05 Matthew Young, Ph.D.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-04 Matthew Young, Ph.D.
Iyer, Prasad G.

Mayo Clinic Arizona
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 2R01CA241164-07 Matthew Young, Ph.D.
Jiang, Feng

Biotarget Dx Llc
United States

Plasma microRNA biomarkers for lung cancer diagnosis 7UH3CA251139-05 Guillermo Marquez, Ph.D.
Justilien, Verline

Mayo Clinic Jacksonville
United States

ECT2 Isoform Switch in Pancreatic Cancer. 1R21CA296671-01 Matthew Young, Ph.D.
Kanwal, Fasiha

Baylor College Of Medicine
United States

Risk Stratification for and Early Detection of Liver Cancer 5U01CA230997-08 Sidney Fu, M.D.
Kibel, Adam S

Brigham And Women'S Hospital
United States

Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer 5U01CA268810-03 Guillermo Marquez, Ph.D.
Kirkwood, Kimberly Saunders

University Of California, San Francisco
United States

Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer 5U01CA282269-02 Matthew Young, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-cancer Early Detection 2R01CA214679-08 Matthew Young, Ph.D.
Klein, Alison P

Johns Hopkins University
United States

Improving Management of patients at High Risk of Pancreatic Cancer 1R01CA299421-01 Matthew Young, Ph.D.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-04 Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-03 Wendy Wang, Ph.D., M.Sc.
Lampe, Paul D.

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 5R01CA281801-03 Guillermo Marquez, Ph.D.